Author

Marnix Jansen

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: PRELIMINARY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: PRELIMINARY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)

Marnix Jansen  et al.

TRACKING GENETIC AND TRANSCRIPTOMIC CHANGES IN OESOPHAGEAL ADENOCARCINOMA DURING NEOADJUVANT TREATMENT
TRACKING GENETIC AND TRANSCRIPTOMIC CHANGES IN OESOPHAGEAL ADENOCARCINOMA DURING NEOADJUVANT TREATMENT

Marnix Jansen  et al.

GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS
GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS

Marnix Jansen  et al.

TRACING THE GENETIC AND EPIGENETIC HISTORY OF INTESTINAL METAPLASIA IN THE CHRONICALLY INFLAMED STOMACH TO DEVELOP A MODEL OF PRE-TUMOUR PROGRESSION
TRACING THE GENETIC AND EPIGENETIC HISTORY OF INTESTINAL METAPLASIA IN THE CHRONICALLY INFLAMED STOMACH TO DEVELOP A MODEL OF PRE-TUMOUR PROGRESSION

Marnix Jansen  et al.

UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT’S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC
UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT’S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC

Marnix Jansen  et al.

RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS
RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS

Marnix Jansen  et al.

Item 1 - 6 / 6
1